Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples